Biofrontera (NASDAQ:BFRI) stock is catching the eyes of investors on Wednesday following a bullish price prediction. Source: Odua Images via Shutterstock Starting with the price prediction, Roth Capital analyst Jonathan Aschoff initiated coverage of BFRI stock with a buy rating and $20 price target. The analyst believes the stock is poised for growth thanks to…